TCRT ALAUNOS THERAPEUTICS INC Management Changes 8-K Filing 2025 - Board Compensation On April 13, 2025, Alaunos Therapeutics' Board of Directors chose to receive $139,000 in deferred fees as equity, issuing 38,269 shares valued at $111,750 and granting stock options worth $27,250.Get access to all SEC 8-K filings of the ALAUNOS THERAPEUTICS INC